Prevention of fetal growth retardation with low-dose aspirin: findings of the EPREDA trial

MLA

S. Uzan, et al. “Prevention of Fetal Growth Retardation with Low-Dose Aspirin: Findings of the EPREDA Trial.” The Lancet, vol. 337, June 1991, pp. 1427–31. EBSCOhost, https://doi.org/10.1016/0140-6736(91)93124-r.

APA

S. Uzan, M. Beaufils, G. Breart, B. Bazin, C. Capitant, & J. Paris. (1991). Prevention of fetal growth retardation with low-dose aspirin: findings of the EPREDA trial. The Lancet, 337, 1427–1431. https://doi.org/10.1016/0140-6736(91)93124-r

Chicago

S. Uzan, M. Beaufils, G. Breart, B. Bazin, C. Capitant, and J. Paris. 1991. “Prevention of Fetal Growth Retardation with Low-Dose Aspirin: Findings of the EPREDA Trial.” The Lancet 337 (June): 1427–31. doi:10.1016/0140-6736(91)93124-r.